Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experience
- 1 April 1993
- Vol. 71 (7) , 2358-2370
- https://doi.org/10.1002/1097-0142(19930401)71:7<2358::aid-cncr2820710730>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Association of interleukin-2 therapy with staphylococcal bacteremiaCancer, 1991
- Thrombocytopenia during immunotherapy with interleukin-2 by constant infusionThe American Journal of Medicine, 1990
- Recombinant Interleukin-2 and Adoptive Immunotherapy Alternated With Dacarbazine Therapy in Melanoma: A National Biotherapy Study Group TrialJNCI Journal of the National Cancer Institute, 1990
- Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinomaThe Lancet, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958